KISS1 and ovarian hyperstimulation syndrome: One of the most significant studies on the use of kisspeptin as an ovulation trigger was conducted by Abbara et al. [15], who evaluated the efficacy and safety of kisspeptin-54 in women at high risk of developing OHSS during IVF treatment.